136 related articles for article (PubMed ID: 12627874)
1. Leptin causes nitric-oxide independent coronary artery vasodilation in humans.
Matsuda K; Teragawa H; Fukuda Y; Nakagawa K; Higashi Y; Chayama K
Hypertens Res; 2003 Feb; 26(2):147-52. PubMed ID: 12627874
[TBL] [Abstract][Full Text] [Related]
2. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
3. Magnesium causes nitric oxide independent coronary artery vasodilation in humans.
Teragawa H; Kato M; Yamagata T; Matsuura H; Kajiyama G
Heart; 2001 Aug; 86(2):212-6. PubMed ID: 11454846
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis.
Ueda K; Teragawa H; Kimura M; Matsuda K; Higashi Y; Yamagata T; Oshima T; Yoshizumi M; Chayama K
J Cardiovasc Pharmacol; 2005 Oct; 46(4):534-9. PubMed ID: 16160609
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A
J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366
[TBL] [Abstract][Full Text] [Related]
6. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
Heart; 1997 Nov; 78(5):493-8. PubMed ID: 9415011
[TBL] [Abstract][Full Text] [Related]
8. Importance of nitric oxide in the coronary artery at rest and during pacing in humans.
Nishikawa Y; Ogawa S
J Am Coll Cardiol; 1997 Jan; 29(1):85-92. PubMed ID: 8996299
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.
Shiode N; Nakayama K; Morishima N; Yamagata T; Matsuura H; Kajiyama G
Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
11. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD
Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701
[TBL] [Abstract][Full Text] [Related]
13. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
14. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans.
Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Kubota T; Hirakawa Y; Takeshita A
Circ Res; 1996 Aug; 79(2):331-5. PubMed ID: 8756012
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina.
Kugiyama K; Ohgushi M; Motoyama T; Sugiyama S; Ogawa H; Yoshimura M; Inobe Y; Hirashima O; Kawano H; Soejima H; Yasue H
J Am Coll Cardiol; 1997 Oct; 30(4):920-6. PubMed ID: 9316519
[TBL] [Abstract][Full Text] [Related]
17. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation.
Duffy SJ; Castle SF; Harper RW; Meredith IT
Circulation; 1999 Nov; 100(19):1951-7. PubMed ID: 10556220
[TBL] [Abstract][Full Text] [Related]
18. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
Kato M; Shiode N; Teragawa H; Hirao H; Yamada T; Yamagata T; Matsuura H; Kajiyama G
Intern Med; 1999 May; 38(5):394-400. PubMed ID: 10397075
[TBL] [Abstract][Full Text] [Related]
19. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Di Daniele N; Mores N; Veneziani A; Cardillo C
J Clin Endocrinol Metab; 2013 Mar; 98(3):1235-41. PubMed ID: 23372172
[TBL] [Abstract][Full Text] [Related]
20. Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women.
Parker BA; Tschakovsky ME; Augeri AL; Polk DM; Thompson PD; Kiernan FJ
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1118-26. PubMed ID: 21642502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
